Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manny D Bacolod

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Cancer Drug Targets|June 11, 2021
The Epigenetic Factors that Drive Cancer Drug ResistanceManny D Bacolod
Current Cancer Drug Targets|February 4, 2021
MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer TypesManny D Bacolod, Francis Barany
The Journal of Molecular Diagnostics : JMD|August 17, 2010
Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular PathologyManny D Bacolod, Francis Barany
Annals of Surgical Oncology|February 25, 2011
Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predispositionManny D Bacolod, Francis Barany
Cancers|October 23, 2021
A Unified Transcriptional, Pharmacogenomic, and Gene Dependency Approach to Decipher the Biology, Diagnostic Markers, and Therapeutic Targets Associated with Prostate Cancer MetastasisManny D Bacolod, Francis Barany
Advances in Cancer Research|March 29, 2023
Multi-CpG linear regression models to accurately predict paclitaxel and docetaxel activity in cancer cell linesManny D Bacolod, Paul B Fisher, Francis Barany
Advances in Cancer Research|June 17, 2019
Can CpG methylation serve as surrogate markers for immune infiltration in cancer?Manny D Bacolod, Francis Barany, Paul B Fisher
Advances in Cancer Research|March 20, 2019
Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumorsManny D Bacolod, Francis Barany, Karsten Pilones, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 11, 2026
A Neural Network-Enabled, Enzymatic cfDNA Methylation Assay for Colorectal Cancer Early DetectionManny D Bacolod, Almudena Aguilera-Diaz, Philip Feinberg, et al.
Journal of Personalized Medicine|May 26, 2026
Establishment and Performance Evaluation of a Multiplexed TET2-APOBEC-Mediated cfDNA Methylation Detection Workflow Using qPCR and dPCR ReadoutsAlmudena Aguilera-Diaz, Philip B Feinberg, Jianmin Huang, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Cancer Drug Targets|June 11, 2021
The Epigenetic Factors that Drive Cancer Drug ResistanceManny D Bacolod
Current Cancer Drug Targets|February 4, 2021
MGMT Epigenetics: The Influence of Gene Body Methylation and Other Insights Derived from Integrated Methylomic, Transcriptomic, and Chromatin Analyses in Various Cancer TypesManny D Bacolod, Francis Barany
The Journal of Molecular Diagnostics : JMD|August 17, 2010
Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular PathologyManny D Bacolod, Francis Barany
Annals of Surgical Oncology|February 25, 2011
Molecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predispositionManny D Bacolod, Francis Barany
Cancers|October 23, 2021
A Unified Transcriptional, Pharmacogenomic, and Gene Dependency Approach to Decipher the Biology, Diagnostic Markers, and Therapeutic Targets Associated with Prostate Cancer MetastasisManny D Bacolod, Francis Barany
Advances in Cancer Research|March 29, 2023
Multi-CpG linear regression models to accurately predict paclitaxel and docetaxel activity in cancer cell linesManny D Bacolod, Paul B Fisher, Francis Barany
Advances in Cancer Research|June 17, 2019
Can CpG methylation serve as surrogate markers for immune infiltration in cancer?Manny D Bacolod, Francis Barany, Paul B Fisher
Advances in Cancer Research|March 20, 2019
Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumorsManny D Bacolod, Francis Barany, Karsten Pilones, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 11, 2026
A Neural Network-Enabled, Enzymatic cfDNA Methylation Assay for Colorectal Cancer Early DetectionManny D Bacolod, Almudena Aguilera-Diaz, Philip Feinberg, et al.
Journal of Personalized Medicine|May 26, 2026
Establishment and Performance Evaluation of a Multiplexed TET2-APOBEC-Mediated cfDNA Methylation Detection Workflow Using qPCR and dPCR ReadoutsAlmudena Aguilera-Diaz, Philip B Feinberg, Jianmin Huang, et al.
Pageof 4